Bollschweiler E, Feussner H, Huber F, Siewert J R
Chirurgische Klinik, Technische Universität München.
Langenbecks Arch Chir. 1993;378(5):304-12. doi: 10.1007/BF00183969.
The number of patients subjected to cholecystectomy has increased since the introduction of laparoscopic methods. Therefore, the question of an association between colorectal cancer (CR-Ca) and cholecystectomy (CHE) is again topical. Several studies have been performed investigating the possibility of a link between cholecystectomy and large bowel cancer. The findings recorded in these studies have been varied and in some cases contradictory. In meta-analyses of the different types of studies (prospective and retrospective) the main question, "Is the risk of colorectal cancer higher after cholecystectomy?" was examined. In prospective matched-pairs studies, 1158 patients who had undergone CHE were compared with 1222 controls. The relative risk (RR) was 1.48, and this result was not significant. The four prospective cohort studies compared the frequency of CR-Ca of 22,783 CHE patients with the expected frequency in the population (RR = 0.99). The retrospective studies compared the frequency of previous CHE in 11,797 patients with CR-Ca with the frequency in 33,940 controls without CR-Ca. The calculated odds ratio (O. R.) of the meta-analysis was 1.15, a significant but not clinically relevant increase in risk. Similar results was shown for evaluation of sex difference both in the prospective studies, with an RR of 0.99 for women and 1.00 for men, and in the retrospective studies, with a RR of 1.17 (p < 0.05) for women and 1.09 (n.s.) for men. The results for different location of the tumour show no significant risk differences in prospective studies either for the colon or for the rectum.(ABSTRACT TRUNCATED AT 250 WORDS)
自腹腔镜手术方法引入以来,接受胆囊切除术的患者数量有所增加。因此,结直肠癌(CR-Ca)与胆囊切除术(CHE)之间关联的问题再次成为热门话题。已经进行了多项研究来调查胆囊切除术与大肠癌之间存在联系的可能性。这些研究记录的结果各不相同,在某些情况下甚至相互矛盾。在对不同类型研究(前瞻性和回顾性)的荟萃分析中,研究了主要问题“胆囊切除术后患结直肠癌的风险是否更高?”。在前瞻性配对研究中,将1158例接受CHE的患者与1222例对照进行了比较。相对风险(RR)为1.48,但该结果不显著。四项前瞻性队列研究将22783例CHE患者的CR-Ca发生率与人群中的预期发生率进行了比较(RR = 0.99)。回顾性研究将11797例患有CR-Ca的患者中既往CHE的发生率与33940例无CR-Ca的对照中的发生率进行了比较。荟萃分析计算的优势比(O.R.)为1.15,风险有显著增加但与临床无关。前瞻性研究和回顾性研究在评估性别差异时均显示了类似结果,前瞻性研究中女性RR为0.99,男性为1.00;回顾性研究中女性RR为1.17(p < 0.05),男性为1.09(无统计学意义)。对于肿瘤不同位置的结果,前瞻性研究中无论是结肠癌还是直肠癌,均未显示出显著的风险差异。(摘要截断于250字)